Nils Brunner

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

Journal: BMC cancer

Published: June 15, 2025

Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.

Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.

Journal: International journal of molecular sciences

Published: February 19, 2025

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.

Journal: Investigational new drugs

Published: October 24, 2024

Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia.

Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia.

Journal: Gastroenterology

Published: January 23, 2023

The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.

The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.

Journal: Molecular oncology

Published: September 22, 2021

New use for old drugs: Epirubicin in colorectal cancer.

New use for old drugs: Epirubicin in colorectal cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 30, 2021

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

Journal: Frontiers in oncology

Published: February 18, 2021

Aspects of transition cow metabolomics-Part III: Alterations in the metabolome of liver and blood throughout the transition period in cows with different liver metabotypes.

Aspects of transition cow metabolomics-Part III: Alterations in the metabolome of liver and blood throughout the transition period in cows with different liver metabotypes.

Journal: Journal of dairy science

Published: June 09, 2020

Aspects of transition cow metabolomics-Part I: Effects of a metaphylactic butaphosphan and cyanocobalamin treatment on the metabolome in liver, blood, and urine in cows with different liver metabotypes.

Aspects of transition cow metabolomics-Part I: Effects of a metaphylactic butaphosphan and cyanocobalamin treatment on the metabolome in liver, blood, and urine in cows with different liver metabotypes.

Journal: Journal of dairy science

Published: June 09, 2020

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.

Journal: International journal of molecular sciences

Published: June 07, 2020

Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteers.

Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteers.

Journal: Basic & clinical pharmacology & toxicology

Published: April 23, 2020

An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial.

An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial.

Journal: Cancers

Published: March 24, 2020

Showing 1-12 of 100

Last Updated: 09/26/2026